Nuevocor Company
Clinical-stage A*STAR spin-off developing mechanobiology-based genetic medicines for cardiomyopathies; lead NVC-001 in Phase 1/2 for LMNA dilated cardiomyopathy with FDA Fast Track.
Technology:
Gene Therapies (Diseases Treatment)
Founded Date:
2021-01-01
Industry:
Advanced BioTech R&D
Sub-Industry:
Gene Therapies (Diseases Treatment)
Investors:
ClavystBio
City:
Singapore
Country:
Singapore
